SGLT2 Inhibitor Treatment Is Associated With Reduced Cardiac Glucose Metabolism by Brett W. Sperry, MD, Yazan Almohtasib, MD, Ramy Ghaly, MD, Mohammad Abdel Jawad, MD, Andrew J. Sauer, MD, Timothy M. Bateman, MD

Get full text

Evaluating the Effectiveness of Insulin Plus Oral Medications Versus Oral Anti‐Diabetes Therapy Alone in Patients With Newly Diagnosed Type 2 Diabetes With Very High hbA1c and Acut... by Adeel Ahmad Khan, Fateen Ata, Afia Aziz, Aya Janan Qassim, Ahmed Shukri, Khaled Abdallah Aboujabal, Yazan Almohtasib, Amin Jayyousi, Mohammed Bashir, Haval Surchi

Get full text